Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04351347

The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment

Efficacy of Ivermectin in larger doses in COVID-19 treatment

Recruiting

Interested in participating?

Request Info

Key information

Conditions

COVID

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2 / Phase 3

Primary location

Tanta University

Tanta, 35111, Egypt

Location status: Recruiting

Location contact

Sherief Abd-Elsalam

CONTACT

About this study

Clinical Study Evaluating the Efficacy of Ivermectin in higher doses in COVID-19 treatment

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with covid 19

Exclusion criteria

  • Allergy or side effects to treatment

Treatment and study plan

Ivermectin

Drug

ivermectin

Primary outcomes

  1. Number of patients with improvement or died

    Time frame: 1 month

    The number of patients with improvement or death

Study contacts

Contact information is provided by the study sponsor or research team.

Sherief Abd-Elsalam, ass. prof.

CONTACT

[email protected]

00201147773440

Sponsors and collaborators

Lead sponsor

Tanta University

Other

Registry information

Official study title

Clinical Study Evaluating the Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment

Important dates

Study start
2020
Primary completion
2030
Study completion
2030
First posted
Apr 17, 2020
Registry last updated
Mar 10, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.